Zoetis | ZTS - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
AbbVie USD 10.52B 258M 2026-09
Align Technology USD 821.72M 43.15M 2026-09
Bayer EUR 9.92B 121M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Charles River Laboratories USD 3.23B 387.38M 2026-09
Coherus Biosciences USD 51.83M 2.48M 2025-12
Dentsply International USD 1.36B 4M 2026-09
Eli Lilly USD 10.52B 496M 2026-06
Henry Schein USD 3.27B 8M 2026-09
Idexx Laboratories USD 811.89M 20.87M 2026-09
Illumina USD 525M 374M 2026-09
IQVIA Holdings USD 3.82B 2.05B 2026-09
J&J USD 18.93B 1.09B 2026-09
Laboratory Of America USD 3.39B 117.6M 2026-09
Merck USD 10.75B 5.02B 2026-09
Neogen USD 224.6M 2.4M 2026-06
Pacira USD 1.18B 995.96M 2026-09
Perrigo USD 961.4M 670.9M 2026-09
Pfizer USD 89B 3.81B 2026-09
Phibro Animal Health USD 417.67M 1.04B 2026-09
Quest Diagnostics USD 2.62B 34M 2026-09
Sanofi EUR 10.51B 598M 2026-09
Sanofi EUR 9.92B 941M 2026-06
Zoetis USD 3.3B 155M 2026-09